Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lapatinib and Capecitabine in Elderly HER2+ MBC
NCT01262469Phase 2Completed
- Sponsor
- Unicancer
- Start
- Dec 2009
- Primary completion
- Dec 2011
- Modality
- DNA Intercalators/Alkylators, Irreversible Covalent Inhibitors, RNA-Targeting Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of lapatinib, capecitabine in breast cancer, sponsored by Unicancer. Started Dec 2009; status: completed.
02
Drugs
lapatinibcapecitabine
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT01262469.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01262469.